SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012626
Filing Date
2022-08-08
Accepted
2022-08-08 16:17:21
Documents
85
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cara-20220630x10q.htm   iXBRL 10-Q 2437888
2 EX-10.2 cara-20220630xex10d2.htm EX-10.2 397269
3 EX-31.1 cara-20220630xex31d1.htm EX-31.1 12109
4 EX-31.2 cara-20220630xex31d2.htm EX-31.2 11924
5 EX-32.1 cara-20220630xex32d1.htm EX-32.1 10389
  Complete submission text file 0001558370-22-012626.txt   10947529

Data Files

Seq Description Document Type Size
6 EX-101.SCH cara-20220630.xsd EX-101.SCH 62738
7 EX-101.CAL cara-20220630_cal.xml EX-101.CAL 57802
8 EX-101.DEF cara-20220630_def.xml EX-101.DEF 334270
9 EX-101.LAB cara-20220630_lab.xml EX-101.LAB 521276
10 EX-101.PRE cara-20220630_pre.xml EX-101.PRE 476511
79 EXTRACTED XBRL INSTANCE DOCUMENT cara-20220630x10q_htm.xml XML 2105688
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 221144618
SIC: 2834 Pharmaceutical Preparations